Inventor · disambiguated record
Jason Goldstein
Also filed as: GOLDSTEIN JASON · GOLDSTEIN JASON MARC
5 granted patents·7 pending applications·74 citations·filing 2004–2021
78Inventor score
Files withELAN PHARM INC4PROTHENA BIOSCIENCES LTD2ANDERSON JOHN P1CHILCOTE TAMIE J1ELAN PHARMA INT LTD1
Top patents by PatentIndex Score
12 records- 0195US7358331B2Truncated fragments of alpha-synuclein in Lewy body diseaseELAN PHARM INC·Filed 2005·Granted Apr 15, 2008·43 cites·11 claims
- 0284US7306945B2Truncated fragments of alpha-synuclein in Lewy body diseaseELAN PHARM INC·Filed 2004·Granted Dec 11, 2007·30 cites·11 claims
- 0366US9879071B2Antibodies to alpha synucleinCHILCOTE TAMIE J·Filed 2012·Granted Jan 30, 2018·1 cites·5 claims
- 0463US2009035217A1Truncated Fragments of Alpha-Synuclein in Lewy Body DiseaseELAN PHARM INC·Filed 2008·Application pending·0 cites
- 0561US2018355028A1Antibodies to Alpha SynucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Application pending·0 cites
- 0658US2017204173A1Antibodies to Alpha SynucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Application pending·0 cites
- 0755US2008300206A1Alpha-Synuclein KinaseELAN PHARM INC·Filed 2008·Application pending·0 cites
- 0849US2023242623A1Compositions and methods for the diagnosis and treatment of sars-cov-2 virus infectionGEORGIA TECH RES INST·Filed 2021·Application pending·0 cites
- 0946US2011207796A1Alpha-synuclein kinaseELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 1042US9845349B2Regulating Bacillus anthracis lethal factor activity via an activating epitope regionUS HEALTH·Filed 2015·Granted Dec 19, 2017·0 cites·5 claims
- 1142US2016039874A1Regulating bacillus anthracis lethal factor activity via an activating epitope regionUS OF AMERICA AS REPRESENTED BY TH SECRETART DEPT OF HEALTH AND HUMAN SERVICE·Filed 2013·Application pending·0 cites
- 1238US8148089B2Alpha-synuclein kinaseANDERSON JOHN P·Filed 2010·Granted Apr 3, 2012·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Jason Goldstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →